Zhen H - Search Results

1

Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling Pathway.

Che J, Yue D, Zhang B, Zhang H, Huo Y, Gao L, Zhen H, Yang Y, Cao B. Che J, et al. Among authors: zhen h. Int J Med Sci. 2018 Feb 5;15(4):339-351. doi: 10.7150/ijms.22927. eCollection 2018. Int J Med Sci. 2018. PMID: 29511369 Free PMC article.

2

Lack of association between the unique LMP2 gene polymorphism and the outcome of lung cancer in a population of Chinese Han nationality.

Cao B, Dong S, Su Q, Yan B, Zhen H, Yuan Z, Liu X, Li Y. Cao B, et al. Among authors: zhen h. Hum Immunol. 2012 May;73(5):580-4. doi: 10.1016/j.humimm.2011.12.005. Epub 2012 Jan 10. Hum Immunol. 2012. PMID: 22261389

3

Efficacy and safety of gemcitabine-fluorouracil combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomized controlled trials.

Li Q, Yan H, Liu W, Zhen H, Yang Y, Cao B. Li Q, et al. Among authors: zhen h. PLoS One. 2014 Aug 5;9(8):e104346. doi: 10.1371/journal.pone.0104346. eCollection 2014. PLoS One. 2014. PMID: 25093849 Free PMC article.

4

Association between the genetic variations within TBX21 gene promoter and the clinicopathological characteristics of esophageal squamous cell carcinoma in a high-risk Chinese population.

Li H, Zhen H, Han L, Yan B, Yu J, Zhu S, Cao B. Li H, et al. Among authors: zhen h. Tumour Biol. 2015 May;36(5):3985-93. doi: 10.1007/s13277-015-3042-x. Epub 2015 Jan 11. Tumour Biol. 2015. PMID: 25577251

5

Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients.

Yan H, Li Q, Wang W, Zhen H, Cao B. Yan H, et al. Among authors: zhen h. Sci Rep. 2015 Oct 20;5:15355. doi: 10.1038/srep15355. Sci Rep. 2015. PMID: 26481697 Free PMC article.

6

Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways.

Zhen H, Li G, Zhao P, Zhang Y, Wang J, Yu J, Cao B. Zhen H, et al. Onco Targets Ther. 2020 Dec 1;13:12325-12339. doi: 10.2147/OTT.S276125. eCollection 2020. Onco Targets Ther. 2020. PMID: 33293826 Free PMC article.

7

Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis.

Hu J, Tian R, Ma Y, Zhen H, Ma X, Su Q, Cao B. Hu J, et al. Among authors: zhen h. Front Oncol. 2021 May 27;11:645245. doi: 10.3389/fonc.2021.645245. eCollection 2021. Front Oncol. 2021. PMID: 34123795 Free PMC article.

8

Decreased expression of Dlg5 is associated with a poor prognosis and epithelial-mesenchymal transition in squamous cell lung cancer.

Che J, Wang J, Li H, Zhen H, Shang K, Yang Y, Cao B. Che J, et al. Among authors: zhen h. J Thorac Dis. 2021 May;13(5):3115-3125. doi: 10.21037/jtd-21-752. J Thorac Dis. 2021. PMID: 34164202 Free PMC article.

9

Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials.

Zhao P, Zhen H, Zhao H, Zhao L, Cao B. Zhao P, et al. Among authors: zhen h. BMC Cancer. 2022 Mar 26;22(1):328. doi: 10.1186/s12885-022-09444-0. BMC Cancer. 2022. PMID: 35346117 Free PMC article.

10

Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis.

Zhen H, Tian J, Li G, Zhao P, Zhang Y, Che J, Cao B. Zhen H, et al. BMC Cancer. 2023 Mar 4;23(1):207. doi: 10.1186/s12885-023-10691-y. BMC Cancer. 2023. PMID: 36870981 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

551 results

Search Page

Filters